UK in-home healthcare provider Cera raises $150M to expand its AI platform

Around the world, public health systems have struggled to recover post-pandemic, and in particular, a growing elderly population in Western countries is putting pressure on services, not least in the UK where ‘‘NHS in crisis’ Regular headlines in the media. As a result, private companies, many driven by technology, see a gap in the market. It is with this background that the bestA proprietary software platform and domestic healthcare provider in the UK, has raised $150 million in a mix of debt and equity. The company said it was mostly debt, but declined to give a breakdown and was tight-lipped about its valuation.

The round was led by funds associated with BDT and MSD Partners and Schroders Capital to scale Cera’s platform. The company says it’s highly AI-driven, with proprietary modeling based on its own data, though it admits to using Soma aspects of both Google’s Gemini AI platform as well as Microsoft’s version of ChatGPT.

Cera in 2022 Raised $320 million (£260 million) in an equity and debt financing round, split roughly 50/50.

According to CrunchBase it has 14 investors. Accredited equity investors to date include EarlyMarket, Guinness Ventures, Digital Health. London accelerator, and long-time UK investor Robin Klein.

A Cera spokesperson added that although this is not yet reflected in publicly filed accounts, the company is EBITA-positive in 2023 and free-cashflow positive in 2024 and is “increasingly a self-sustaining business” hence why it is raising this debt round. could

In an interview with TechCrunch, Cera founder and CEO Dr. Ben Maruthappu MBE said: “We’re moving towards profitability, and we have very important niches in how we’re using our technology and AI, and we’re expanding into more services. at home.”

Cera caregivers use its app to plan their work and log patient symptoms. Using its AI modeling, Cera is then able to take that unstructured data (for example, “the patient fell during the night,” etc.) and use it to predict the likelihood that patients will be at greater risk of illness or injury. The company claims it has reduced hospital readmissions by up to 70%, reduced patient falls by 20% and made hospital discharges up to five times faster, it said in a statement.

The company has raised more than $407 million to date in a mix of equity and debt.

UK competitors include Home Instead and Bluebird Care, which use non-proprietary apps to instruct their staff. In the US, Cera’s closest comparisons include Signify Health and CVS Health, both acquired by Nasdaq-listed CVS Health. Another is Honor, which has Raised $625 million to date.

Maruthappu said: “We are taking the pressure off the NHS and supporting it to look after other patients. We have also expanded into other service lines such as providing nursing services, physiotherapy, learning disabilities, physical disabilities and mental health services at home. So we are a much more comprehensive healthcare at home provider.

He also said the AI-driven side of the business is based on the data it collects: “Another key benefit is what we’re doing with technology, more specifically AI… We’re logging information about patients from those visits in our app. It’s now given us the largest in the world. One of the home health care data sets, certainly the largest in Europe, and we’ve been able to analyze the data set in different ways to create algorithms, algorithms that are relevant if someone falls before they do.”

“We can predict a fall of more than 80% a week ago. It’s statistically significant… so we’ve actually reduced falls by over 20% because of our AI algorithm… we can again predict about 83% of hospitalizations a week before they happen… reducing hospitalizations by up to 70%,” He said.

In a statement, Rob Platek, partner and global head of credit at BDT and MSD, said: “Cera has achieved strong growth through its proven ability to leverage technology to deliver exceptional care. We believe Cera is well positioned to further scale its business.”

Cera says it is the UK’s largest non-NHS healthcare provider, covering around 30 million people with 10,000 carers and nurses and working with more than 150 local authorities and two-thirds of the NHS integrated care system.

It claims that an independent analysis conducted by UK consultancy Faculty found Sira’s AI-led home healthcare model saves the UK healthcare system £1 million a day.

Sira is clearly keen to avoid the stigma of healthcare startups like Babylon Health, admittedly a very different business, that have gone bankrupt And was sold for parts after trying to do healthcare with a mere chatbot.